title: Amyloid and non-amyloid carpal tunnel syndrome in patients receiving chronic renal dialysis.
abstract: OBJECTIVE
  To determine the prevalence of amyloid deposits among patients with carpal tunnel syndrome (CTS) receiving dialysis, and to investigate the factors associated with amyloid and non-amyloid CTS.
  
  
  METHODS
  Subjects for this prospective study were dialysis patients who underwent surgery for CTS in the same surgical unit between 1989 and 1997. CTS was diagnosed from clinical and electromyographic (EMG) findings. Systematic standard radiographs and laboratory data were also obtained. Surgical investigations included systematic macroscopic examination and biopsy of the epineurium, flexor retinaculum, synovium, and flexor tendon sheaths. Samples were stained for amyloid and examined by plain and polarized light microscopy, immunohistochemistry, and electron microscopy.
  
  
  RESULTS
  Forty-one samples from 30 patients (11 bilateral cases) were examined. Amyloid deposits were found in 26 samples from 18 patients (7 M, 11 F). Fifteen samples from 12 patients (3 M, 9 F) showed no amyloid deposits. Amyloid CTS was statistically significantly associated with arthralgia and longterm dialysis [mean 13.3 (range 5.5-23) vs 7.5 yrs (range 3 mo-14 yrs)] in non-amyloid CTS. Flexor tenosynovitis and carpal bone erosion occurred more frequently in amyloid CTS. There were no statistically significant differences between the 2 groups in clinical, laboratory or EMG findings, type of dialysis membrane, or frequency of ipsilateral fistula. Only amyloid CTS was recurrent.
  
  
  CONCLUSIONS
  Amyloid deposits were confirmed microscopically in 63.4% of patients. The relatively large number of cases of non-amyloid CTS without signs of dialysis associated arthropathy suggests that CTS is not a satisfactory criterion for diagnosis of dialysis arthropathy or beta2-microglobulin amyloidosis unless the presence of amyloid has been confirmed or duration of dialysis treatment has been at least 15 years.
authors.affiliation: Clinique Rhumatologique, Laboratoire d'Anatomie Pathologique, Centre Hospitalier Universitaire de Nancy and UMR CNRS 7561, Vandoeuvre les Nancy, France. pourel@pharmaco-med.u-nancy.fr
authors.forename: I
authors.initials: I
authors.lastname: Chary-Valckenaere
authors.forename: M
authors.initials: M
authors.lastname: Kessler
authors.forename: D
authors.initials: D
authors.lastname: Mainard
authors.forename: L
authors.initials: L
authors.lastname: Schertz
authors.forename: J
authors.initials: J
authors.lastname: Chanliau
authors.forename: J
authors.initials: J
authors.lastname: Champigneulle
authors.forename: J
authors.initials: J
authors.lastname: Pourel
authors.forename: A
authors.initials: A
authors.lastname: Gaucher
authors.forename: P
authors.initials: P
authors.lastname: Netter
mesh_terms: D000328:Adult; D000368:Aged; D000682:Amyloid / Q000378:metabolism*; D000686:Amyloidosis / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D002349:Carpal Tunnel Syndrome / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D004576:Electromyography; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D000682:Amyloid